Latest news
Cytokinetics’ Myqorzo Launch Is Turning Heads In Cardiology - FinimizeFinimize · Fri, 07 Aug 2026 22:12:36 GMTCYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 18:22:00 GMTCytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target - TipRanksTipRanks · Fri, 07 Aug 2026 16:03:00 GMTCytokinetics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 03:19:33 GMTCytokinetics, Incorporated (CYTK) latest stock news and headlines – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 00:16:11 GMTCytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launch - ChartMillChartMill · Thu, 06 Aug 2026 20:49:51 GMTCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:00:00 GMTCytokinetics' aficamten trial met both primary endpoints; Q4 filing expected - Stock TitanStock Titan · Thu, 06 Aug 2026 20:00:00 GMT